Conference LibraryGated
Lancet 2025 · In-vivo BCMA CAR T-cell therapy for r/r MM (ESO-T01 companion)
[No abstract available · Lancet letter-type article 不附 abstract] Per Lancet 2025-07-19 letter · 描述 ESO-T01 in vivo BCMA CAR-T 在 r/r multiple myeloma 9-patient 队列的较早期数据 · companion to Nature Medicine 2026 (PMID 41882404) phase 1 report
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_intel_seed_2026-05-16
- evidence_grade
- A
- category
- in_vivo_car_t_clinical_paper
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "early phase 1 clinical data · NOT validated late-stage outcome"
- journal
- Lancet
- year
- 2025
- authors
- Jia Xu,Heng Mei
- abstract_snippet
- [No abstract available · Lancet letter-type article 不附 abstract] Per Lancet 2025-07-19 letter · 描述 ESO-T01 in vivo BCMA CAR-T 在 r/r multiple myeloma 9-patient 队列的较早期数据 · companion to Nature Medicine 2026 (PMID 41882404) phase 1 report
- pmid
- 40617243
- doi
- 10.1016/S0140-6736(25)01030-X
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.